BURLINGTON, Mass., Jan. 5, 2023
/PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that
Company management will participate in the 41st Annual J.P. Morgan
Healthcare Conference in San Francisco,
CA, on Wednesday, January 11,
2023, which includes a presentation beginning at
3:45 pm PST. The live webcast can be
accessed through the Azenta investor relations website at
https://investors.azenta.com/events. A replay of the webcast will
be available following the event.
About Azenta Life
Sciences
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life
sciences solutions worldwide, enabling impactful breakthroughs and
therapies to market faster. Azenta provides a full suite of
reliable cold-chain sample management solutions and genomic
services across areas such as drug development, clinical research
and advanced cell therapies for the industry's top pharmaceutical,
biotech, academic and healthcare institutions globally.
Azenta is headquartered in Massachusetts, with operations
in North America, Europe and Asia. For more
information, please visit www.azenta.com.
INVESTOR CONTACTS:
Sara Silverman
Head of Investor Relations
978.262.2635
ir@azenta.com
Sherry Dinsmore
978.262.2400
sherry.dinsmore@azenta.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/azenta-to-participate-in-the-41st-annual-jp-morgan-healthcare-conference-301714256.html
SOURCE Azenta